循证医学进展预防对比剂肾病指南和专家共识.pptxVIP

循证医学进展预防对比剂肾病指南和专家共识第1页/共48页第2页/共48页CIN---The 3rd tough PCI problem in high risk patients More complicated procedure, More consumption of CM, higher risk in complex PCICIN became the 3rd tough problem in PCI following restenosis and stent thrombosisUtilization of CM reasonable to prevent CIN第3页/共48页对比剂肾病 (CIN)CIN的发生率取决于其定义1CIN常用定义为 –血清肌酐值SCr升高 ?44.2 μmol/l (0.5 mg/dl) 和/或48-72小时内升高 ?25%2与未发生CIN的患者相比， CIN与下列后果有关– 住院时间延长3– 死亡率升高4 1.McCullough PA et al. Am J Med 1997; 103: 368-375.2.Morcos SK et al. Eur Radiol 1999; 9: 1602-1613.3. Gruberg L et al. J Am Coll Cardiol 2000; 36: 1542-15